Studies have demonstrated that inhibiting the upregulation of SLC27A2 in polymorphonuclear myeloid-derived suppressor cells can weaken their immunosuppressive effects and inhibit tumor progression (Veglia et al. 2019). This evidence concerns the gene SLC27A2 and neoplasm.